NCRC
The 2019 Novel Coronavirus Research Compendium (NCRC) is a centralized, publicly available resource that rapidly curates and reviews the emerging scientific evidence about SARS-CoV-2 and COVID-19. Our goal is to provide accurate, relevant information for global public health action by clinicians, public health practitioners, and policy makers.
Latest preprint reviews
-
BNT162b2 Vaccine‐Associated Myo/Pericarditis in Adolescents: A Stratified Risk‐Benefit Analysis
This article has 3 authors: -
Shedding of infectious SARS-CoV-2 despite vaccination
This article has 18 authors: -
SARS-CoV-2 vaccine breakthrough infections with the alpha variant are asymptomatic or mildly symptomatic among health care workers
This article has 22 authors: -
Persistent COVID-19 symptoms in a community study of 606,434 people in England
This article has 8 authors: -
Viral infection and transmission in a large, well-traced outbreak caused by the SARS-CoV-2 Delta variant
This article has 46 authors: -
Elapsed time since BNT162b2 vaccine and risk of SARS-CoV-2 infection: test negative design study
This article has 9 authors: -
Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine breakthrough infections: a multicentre cohort study
This article has 19 authors: -
SARS-CoV-2 infection in free-ranging white-tailed deer ( Odocoileus virginianus )
This article has 20 authors: -
COVID-19 vaccine effectiveness against hospitalizations and ICU admissions in the Netherlands, April- August 2021
This article has 13 authors: -
Vaccination with BNT162b2 reduces transmission of SARS-CoV-2 to household contacts in Israel
This article has 7 authors: